"In The Spotlight" Archive
Three teams headed by researchers at the Stanford University School of Medicine recently received $51.7 million from the California Institute for Regenerative Medicine to develop
FDA-approved therapies within the next four years.
The team headed by Alfred Lane, MD, professor of dermatology will receive $11.7 million to use stem cell therapy to treat epidermolysis bullosa or EB, a devastating genetic skin condition. The international group also includes Stanford stem cell expert Marius Wernig, MD, as well as Stanford researchers Paul Khavari, MD, PhD, Peter Marinkovich, MD, Howard Chang, MD, PhD, Anthony Oro, MD, PhD, and
Seung Kim, MD.
Howard Chang, MD, PhD.
associate professor of dermatology and a member of Stanford's Cancer Center on his latest research...More
Youn Kim, MD, (second from left, front row)
professor of dermatology, has been appointed as the first recipient of the Joanne and Peter Haas Jr. Professorship for Cutaneous Lymphoma Research...More
Stanford research discovers that specialized skin cells use a mapping system to identify where they belong in the body. John Rinn, PhD, a postdoctoral scholar in the laboratory ofHoward Chang, MD, PhD, assistant professor of dermatology, speaks on their research...More
Illustration by Christoph Niemann